ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Research Projects Banner

Research Projects

Research in ASTHI: Pre-clinical development of CDRI optimized lead molecules as dual osteogenic and muscle anabolic agents

Implementing Organization

CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow
Principal Investigator
Dr Naibedya Chattopadhyay
Scientist
|
CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow

About

Objective: Nature-inspired synthesis of medicarpin and their derivativities as a novel dual-acting drug candidate for the treatment of osteoporosis: preclinical development. Evaluation of CDRI osteogenic lead medicarpin (water-soluble salt) in skeletal muscle atrophy. Engineered self-assembled composites bearing medicarpinl potential osteogenic agents for spatial drug targeting and bone regeneration.

Related Research

View All
Funding Organization
Funding Organization
Council of Scientific and Industrial Research
Quick Information
Area of Research
Life Sciences & Biotechnology
Focus Area
Osteoporosis
Start Year
2020
End Year
2023
Status
Completed
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop